Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Filings indexed 362 across all filing types
Latest filing 2025-09-11 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in equity relationships between shareholders of Shanghai MicroPort EP Medical Technology Co., Ltd., specifically the termination of a concerted action relationship between two major shareholders without any change in the number of shares held. The document references relevant Chinese securities laws and disclosure rules, and provides detailed information about the shareholders, their holdings, and the nature of the equity change. There is no indication of financial statements, audit information, earnings data, or other report types. The content is focused on reporting changes in shareholding and related disclosures. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or related shareholder agreements. The document length (7778 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is MRQ with high confidence.
2025-09-11 Chinese
关于参加2025年半年度科创板医疗器械及医疗设备行业集体业绩说明会的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement from Shanghai MicroPort EP MedTech Co., Ltd. about its participation in the 2025 semi-annual industry collective performance briefing for the medical device sector hosted by the Shanghai Stock Exchange. It references the company's 2025 semi-annual report already published on August 27, 2025, and provides details about the upcoming performance briefing meeting, including date, time, location, participation method, and contact information. The document does not contain actual financial statements or detailed financial analysis but serves to inform investors about the event where the company will discuss its semi-annual results. The document length is short (1592 characters) and primarily serves as a notice of the briefing event rather than the report itself. According to the classification rules, such announcements about the timing and details of report presentations or performance briefings are classified as Report Publication Announcements (RPA).
2025-09-08 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025 半年度报告摘要' which translates to '2025 Half-Year Report Summary'. It contains detailed financial data such as total assets, net profit, earnings per share, and shareholder information for the half-year period. The document includes management discussion and analysis references and financial metrics typical of an interim or quarterly report. The length is 3419 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
第三届监事会第十六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shanghai MicroPort EP MedTech Co., Ltd. regarding the approval of the 2025 semi-annual report and related financial matters. It references the 2025 semi-annual report and a special report on the use of raised funds, but does not contain the actual financial statements or detailed financial data itself. The document is short (1359 characters) and mainly announces the meeting decisions and voting results. It also directs readers to the full reports published on the Shanghai Stock Exchange website. Therefore, this document is an announcement of meeting resolutions and approvals rather than the report itself. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice, not as the interim report (IR) or annual report (10-K).
2025-08-26 Chinese
2025年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2025 Half-Year Special Report on the Deposit and Actual Use of Raised Funds" by Shanghai MicroPort EP MedTech Co., Ltd. It details the management, storage, and usage of funds raised through a public stock issuance, including specific amounts, bank accounts, project investments, and approvals by the board and supervisory committee. The document includes detailed financial figures related to fundraising and usage for the half-year period ending June 30, 2025. It is a specialized report focused on the use of capital raised by the company, not a general financial report or earnings release. This type of document corresponds to a Capital/Financing Update (CAP) as it provides updates on fundraising and capital usage, rather than a full annual or interim financial report or an announcement of a report publication. The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2025-08-26 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司使用暂时闲置募集资金进行现金管理的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from Huatai United Securities regarding Shanghai MicroPort EP MedTech Co., Ltd.'s use of temporarily idle raised funds for cash management. It references regulatory approvals, fundraising details, board meeting approvals, and compliance with securities regulations. The document is a formal verification and opinion report by the sponsor on the company's cash management of idle raised funds, not a financial report or earnings release. It is not an announcement of a report publication but a substantive verification opinion. This fits the category of a Regulatory Filing (RNS) as it is a compliance and verification document related to fundraising and cash management, not a full annual or interim report, nor a capital update or earnings release.
2025-08-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.